1353669-97-2

Upstream product

• 1018784-63-8 C₂₈H₃₂O₅ 
• 1367876-75-2 C₂₈H₃₂O₅ 
• 1367876-54-7 C₂₇H₃₄O₄ 
• 18162-48-6 tert-butyldimethylsilyl chloride 
• 1353669-94-9 (1R,2S,3R,4S,8aR)-2,3-bis(benzyloxy)-4-hydroxy-4-propyl-1,2,3,4,6,7,8,8a-octahydronaphthalen-1-yl formate 

Downstream Products

• 1353669-99-4 (4aS,5R,6R,7R,8R,8aR)-6,7-bis(benzyloxy)-5-[(tert-butyldimethylsilyl)oxy]-8,8a-dihydroxy-8-propyloctahydronaphthalen-1(2H)-one 
• 1353669-98-3 (1R,2R,3R,4R,4aS,8R,8aS)-2,3-bis(benzyloxy)-4-[(tert-butyldimethylsilyl)oxy]-1-propyldecahydronaphthalene-1,8,8a-triol 
• 1353669-90-5 (4aS,5R,6S,7R,8R,8aR)-6,7-bis(benzyloxy)-5,8,8a-trihydroxy-8-propyl-4a,5,6,7,8,8a-hexahydronaphthalen-1(4H)-one 

Relevant academic research and scientific papers

Synthesis of an A'B' precursor to angelmicin B: Product diversification in the Suarez lactol fragmentation

We describe a synthetic strategy for the angelimicin family of anthraquinoid natural products that involves converting a central highly oxygenated decalin intermediate to the AB and A'B' subunits. Herein, we report the synthesis of the bicyclic A'B' subun